NYSE:USNA - USANA Health Sciences Stock Price, Price Target & More

USANA Health Sciences trades on the New York Stock Exchange (NYSE) under the ticker symbol "USNA."

USANA Health Sciences declared that its board has approved a share repurchase program on Wednesday, July 26th 2017, which permits the company to buyback $64,600,000.00 in outstanding shares, according to EventVestor. This buyback authorization permits the company to repurchase up to 46% of its shares through open market purchases. Shares buyback programs are usually an indication that the company's management believes its stock is undervalued.

USANA Health Sciences, Inc. (NYSE:USNA) announced its quarterly earnings data on Tuesday, April, 24th. The company reported $1.19 earnings per share (EPS) for the quarter, topping the Zacks' consensus estimate of $1.05 by $0.14. The company had revenue of $292 million for the quarter, compared to analyst estimates of $268.93 million. USANA Health Sciences had a return on equity of 27.92% and a net margin of 6.47%. USANA Health Sciences's quarterly revenue was up 14.4% on a year-over-year basis. During the same period last year, the company posted $0.91 EPS. View USANA Health Sciences' Earnings History.

USANA Health Sciences is scheduled to release their next quarterly earnings announcement on Tuesday, July, 24th 2018. View Earnings Estimates for USANA Health Sciences.

USANA Health Sciences issued an update on its FY18 earnings guidance on Tuesday, April, 24th. The company provided EPS guidance of $4.25-4.55 for the period, compared to the Thomson Reuters consensus EPS estimate of $4.37. The company issued revenue guidance of $1.13-1.17 billion, compared to the consensus revenue estimate of $1.12 billion.

2 analysts have issued 12 month price targets for USANA Health Sciences' shares. Their forecasts range from $95.00 to $95.00. On average, they anticipate USANA Health Sciences' stock price to reach $95.00 in the next twelve months. This suggests that the stock has a possible downside of 13.6%. View Analyst Ratings for USANA Health Sciences.

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for USANA Health Sciences in the last year. There are currently 2 hold ratings for the stock, resulting in a consensus recommendation of "Hold."

Some companies that are related to USANA Health Sciences include Stada Arzneimittel (STDAF), Foamix Pharmaceuticals (FOMX), Chromadex (CDXC), Mediwound (MDWD), Natural Alternatives International (NAII), Pharmacyte Biotech (PMCB), Mannatech (MTEX), China Jo-Jo Drugstores (CJJD), GLG Life Tech (GLGLF), Cyanotech (CYAN), ImmuDyne (IMMD), FitLife Brands (FTLF), Nutra Pharma (NPHC), Tauriga Sciences (TAUG) and True Drinks Holdings, Inc Common Stock (TRUU).

Headlines about USNA stock have been trending positive on Wednesday, Accern Sentiment reports. The research group ranks the sentiment of media coverage by monitoring more than 20 million blog and news sources in real time. Accern ranks coverage of companies on a scale of negative one to one, with scores closest to one being the most favorable. USANA Health Sciences earned a media sentiment score of 0.29 on Accern's scale. They also assigned news stories about the company an impact score of 46.29 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the company's share price in the near term.

USANA Health Sciences' stock is owned by a variety of of institutional and retail investors. Top institutional shareholders include WENTZ MYRON W (43.80%), Bank of Montreal Can (0.02%), Campbell & CO Investment Adviser LLC (0.01%) and Amalgamated Bank (0.01%). Company insiders that own USANA Health Sciences stock include Daniel A Macuga, David Mulham Mulham, Deborah Woo, G Doug Iiekking, Gilbert A Fuller, Global Ltd Gull, James Bramble, Jim Brown, Kevin Guest, Myron W Wentz, Paul A Jones, Robert Auciaux and Walter Noot. View Institutional Ownership Trends for USANA Health Sciences.

USNA stock was bought by a variety of institutional investors in the last quarter, including Bank of Montreal Can, Campbell & CO Investment Adviser LLC and Amalgamated Bank. View Insider Buying and Selling for USANA Health Sciences.

Shares of USNA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of USNA stock can currently be purchased for approximately $109.95.

USANA Health Sciences has a market capitalization of $2.62 billion and generates $1.05 billion in revenue each year. The company earns $62.53 million in net income (profit) each year or $4.06 on an earnings per share basis. USANA Health Sciences employs 1,810 workers across the globe.

USANA Health Sciences' mailing address is 3838 West Parkway Blvd, Salt Lake City UT, 84120. The company can be reached via phone at 801-954-7100 or via email at [email protected]